Search research articles
Contact Us
Filters
Showing results (11-20 of 131) with videos related to
Page
of 14
Sort By:
The American Journal of Medicine
|
November 28, 2025
Detection, treatment and prevention of tuberculosis
Edward J Goetzl
The American Journal of Medicine
|
August 28, 2024
Current Developments in Alzheimer's Disease
Edward J Goetzl
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 3, 2011
Is aging a drug target?
Edward J Goetzl
Regulatory Peptides
|
August 29, 2006
Hypothesis: VPAC G protein-coupled receptors for vasoactive intestinal peptide constitute a dynamic system for signaling T cells from plasma membrane and nuclear membrane complexes
Edward J Goetzl
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 30, 2006
Diverse pathways for nuclear signaling by G protein-coupled receptors and their ligands
Edward J Goetzl
Annals of the New York Academy of Sciences
|
December 17, 2008
Neural signaling opportunities for novel diagnostic approaches and therapies. Preface
Edward J Goetzl
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 5, 2023
An emerging spectrum of therapeutic targets for Alzheimer's disease
Edward J Goetzl
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 29, 2020
Advancing medicine for Alzheimer's disease: A plasma neural exosome platform
Edward J Goetzl
The American Journal of Medicine
|
September 24, 2025
Microbiomes in health, diseases and therapeutics
Edward J Goetzl
The Journal of Biological Chemistry
|
January 29, 2002
Vasoactive intestinal peptide receptor-1 (VPAC-1) is a novel gene target of the hemolymphopoietic transcription factor Ikaros
Glenn Dorsam, Edward J Goetzl
Page
of 14
Search research articles
Search
Showing results (11-20 of 131) with videos related to
Sort By:
Page
of 14
The American Journal of Medicine
|
November 28, 2025
Detection, treatment and prevention of tuberculosis
Edward J Goetzl
The American Journal of Medicine
|
August 28, 2024
Current Developments in Alzheimer's Disease
Edward J Goetzl
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 3, 2011
Is aging a drug target?
Edward J Goetzl
Regulatory Peptides
|
August 29, 2006
Hypothesis: VPAC G protein-coupled receptors for vasoactive intestinal peptide constitute a dynamic system for signaling T cells from plasma membrane and nuclear membrane complexes
Edward J Goetzl
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
December 30, 2006
Diverse pathways for nuclear signaling by G protein-coupled receptors and their ligands
Edward J Goetzl
Annals of the New York Academy of Sciences
|
December 17, 2008
Neural signaling opportunities for novel diagnostic approaches and therapies. Preface
Edward J Goetzl
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
October 5, 2023
An emerging spectrum of therapeutic targets for Alzheimer's disease
Edward J Goetzl
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 29, 2020
Advancing medicine for Alzheimer's disease: A plasma neural exosome platform
Edward J Goetzl
The American Journal of Medicine
|
September 24, 2025
Microbiomes in health, diseases and therapeutics
Edward J Goetzl
The Journal of Biological Chemistry
|
January 29, 2002
Vasoactive intestinal peptide receptor-1 (VPAC-1) is a novel gene target of the hemolymphopoietic transcription factor Ikaros
Glenn Dorsam, Edward J Goetzl
Page
of 14